SANGHA Research Systems
Project / 03
Research note · 2026
Cross-cohort EEG / disease-process phenotyping

A conserved EEG deformation?

SANGHA Research Systems · Thomas Gross, PhD

Two independently sourced case–control cohorts representing distinct positions in a hypothesized disease process move in the same direction under a shared EEG observable. The directional correspondence recurs across independently acquired cohorts. The stronger claim—that both observations lie on one disease-progressive coordinate—is not established.

Direction · concordantBase alignment · strongPath invariance · unresolved
Two cohorts / one observable

The signal survives replication. The interpretation does not get a free pass.

The shared observable is q = log(σ12–16 Hz / α8–12 Hz), evaluated through the same deformation-estimation pipeline in two independently acquired case–control EEG cohorts.

The cohort-specific disease displacements are compared as vectors under a common representation; cos θ reports their directional alignment, while the orthogonal residual reports the component of one deformation not captured by the shared direction.

Cohort A Δq
−0.511
median disease displacement
Cohort B Δq
−0.278
median disease displacement
cos θ
0.933
base directional alignment
orthogonal residual
0.360
relative residual magnitude
Shared sign / unequal magnitude
REFERENCECOHORT A −0.511
REFERENCECOHORT B −0.278
Supported
Shared directional deformation
Observed
Session / channel / operator sensitivity
Not established
Single progression coordinate
Identification problem

What turns concordance into a disease-process coordinate?

What statistical structure would justify treating these two concordant disease-associated deformations as observations of one latent progressive coordinate rather than two related but phenotype-specific contrasts?

A stronger claim would require prespecified stability across resampling, measurement choices, and independent data, together with temporal or predictive information beyond the cross-sectional contrasts used to define the shared direction.

Open question

What evidence would justify the stronger claim?

The next step is not another favorable correlation. It is a prespecified test of whether the shared component remains stable across independent data and carries information not used to define it.

Until that evidence exists, the result remains a reproducible cross-cohort correspondence rather than a disease-progression coordinate.

Phenotype Is Compiled →Read the broader representational argument behind the identification problem.
Background →Conventional scientific lineage and research practice, separate from the project claims.

Inference boundary. These analyses are cross-sectional and cohort-comparative. They do not establish longitudinal transition between the cohorts, causality, or a unique latent disease trajectory.